Oncology CPT & HCPCS Families Coded
Clean Claim Rate
Years in U.S. Medical Billing
Oncology practices without strong administration hierarchy and prior authorization controls commonly lose 10 to 20% of revenue to chemotherapy sequencing errors, missed drug wastage billing, and authorization delays that stall treatment and payment together. Most of it traces back to a small number of recurring coding decisions, which is exactly where specialty-specific billing pays for itself.
Where Oncology billing actually goes wrong
Oncology billing, done right
The coding decisions that cause most oncology denials, handled by billers who know the specialty, not just the CPT book.
Chemotherapy Administration Hierarchy
Since chemotherapy administration follows its own hierarchy distinct from standard infusion coding, with separate treatment for IV push, initial infusion, and sequential drugs, sequencing errors directly affect reimbursement. We sequence every chemotherapy visit to match what the documentation actually supports.
High-Dollar J-Code Precision
Because chemotherapy and biologic drugs carry some of the highest per-unit costs in medicine, a J-code or dosage-unit mismatch creates outsized financial risk compared to lower-cost specialties. We verify drug code and dosage-to-unit alignment before every high-dollar claim goes out.
Prior Authorization Tracking
Since nearly every chemotherapy regimen and targeted therapy requires prior authorization tied to diagnosis, staging, and treatment history, we track authorization status from the treatment-planning stage forward, not after a denial arrives.
Drug Wastage Documentation
Because chemotherapy drugs often come in single-use vials at high per-unit cost, unbilled wastage adds up to meaningful lost revenue fast. We document and bill wastage under modifier JW as a distinct line item on every applicable claim.
Radiation Therapy Code Coordination
Since radiation therapy billing runs on a separate code structure covering planning, simulation, and delivery phases, we code each phase distinctly rather than treating radiation like a single bundled service.
Modifier 25 for Same-Day Oncology Visits
When an oncologist evaluates a patient and delivers chemotherapy on the same day, modifier 25 signals the E/M service was separately identifiable. We apply it only when documentation clearly supports two distinct services.
Oncology-specific, not generalist
Billers who know cath lab bundling rules
A biller who treats every specialty the same way will sequence a chemotherapy visit incorrectly or miss wastage on a high-cost vial, and the dollar impact of that single error dwarfs what the same mistake would cost in most other specialties. Since oncology revenue leaks rarely sit in one place, they instead spread across administration hierarchy accuracy, high-dollar J-code precision, and prior authorization speed that most billers never learn to manage together. Ultimately, treating oncology like standard infusion billing is exactly where the revenue disappears, and at oncology's dollar amounts, that disappearance is significant.
Talk to a specialistCaught before submission
Fewer denials, faster reimbursement
Oncology practices without strong front-end controls commonly see first-pass denial rates of 12 to 20%, driven largely by chemotherapy sequencing errors, missed drug wastage billing, and prior authorization delays that stall both treatment and payment. Because we catch these before the claim goes out rather than after the denial comes back, practices see cleaner claims from the first submission and faster payment on the field's highest-dollar services.
See how it works
What we hold ourselves to
Our values, in practice
Intake & Systems Review
We audit current chemotherapy administration coding and prior authorization workflows.
Charge Capture & Coding
Encounters get coded with correct chemotherapy hierarchy, J-codes, and dosage-matched units.
Claims Scrubbing
Claims run through payer-specific edits before submission, with extra review on high-dollar lines.
Submission & Tracking
Clean claims go out daily, and every claim gets tracked to resolution.
Denial Management
Denials get corrected and resubmitted within payer timely-filing windows.
Authorization Monitoring
Regimen authorizations get tracked from treatment planning through approval to prevent treatment delays.
Reporting
Monthly reports show clean claim rate, denial trends, and days in A/R by drug and treatment category.
Questions, answered
Oncology billing, answered
What oncology practices ask most before switching billing partners.
What makes oncology billing different from other infusion-based specialties?
Oncology billing combines chemotherapy administration coding, which follows its own strict hierarchy, with extremely high-dollar drug billing under precise J-codes and one of the heaviest prior authorization burdens in medicine. Because the financial stakes per claim run so much higher than in most other specialties, a single coding or sequencing error carries outsized revenue risk.
Why does chemotherapy administration hierarchy matter so much?
Chemotherapy administration uses its own hierarchy distinct from standard infusion coding, with different codes and reimbursement rates for IV push, initial infusion, and sequential drugs given during the same visit. Sequencing this incorrectly directly changes how the visit reimburses, especially on multi-drug treatment days.
Why does oncology require so much prior authorization?
Nearly every chemotherapy regimen, targeted therapy, and immunotherapy requires payer pre-approval, often tied to specific diagnosis codes, cancer staging, and documented prior treatment lines. Because treatment frequently can't begin until authorization clears, delays in this process affect both patient care timelines and practice cash flow simultaneously.
Is chemotherapy drug wastage billable?
Yes, when a single-use vial isn't fully administered and the unused portion is properly documented, modifier JW allows that wastage to be billed separately. Given how expensive many oncology drugs are per unit, unbilled wastage represents meaningful lost revenue that adds up quickly across a busy infusion suite.
How is radiation therapy billed differently from chemotherapy?
Radiation therapy uses an entirely separate code structure covering distinct phases, including treatment planning, simulation, and the actual delivery of radiation, rather than the drug-and-administration model used for chemotherapy. Practices offering both need billing that treats these as fundamentally different coding systems, not variations of the same process.
What denial rate should an oncology practice expect?
A well-run oncology billing operation should see a denial rate under 7%, with first-pass clean claims above 93%. Practices without strong administration hierarchy and prior authorization controls commonly see denial rates well above that, and given oncology's per-claim dollar amounts, even a small percentage difference represents substantial revenue.
Find out how much revenue
your practice is leaving on the table.
Get a free, no-obligation revenue audit. We'll analyze your billing and show you the exact dollars you could be collecting.
No contracts to review. No pressure. Just numbers.